Literature DB >> 26003310

Prevalence of chronic pulmonary aspergillosis in patients with tuberculosis from Iran.

M T Hedayati1, Y Azimi, A Droudinia, B Mousavi, A Khalilian, N Hedayati, D W Denning.   

Abstract

In patients with preexisting lung disease, especially a cavity, Aspergillus can infect the surface of the cavity, causing chronic cavitary pulmonary aspergillosis (CCPA), and may form an aspergilloma, collectively called chronic pulmonary aspergillosis (CPA). In the present study, we assessed tuberculosis (TB) patients for CPA based on culture and serological methods. During a period of 1 year (from March 2013 to March 2014), we studied 124 patients with TB (94 with current TB and 30 with previous TB) at Masih Daneshvari Hospital in Tehran, Iran. Sputum specimens were analyzed by direct microscopic examination (DME) and fungal culture. The clinical and radiological features of all patients were recorded, to categorize the patients into CCPA and aspergilloma. All patients were screened for serum-specific IgG against A. fumigatus, by enzyme-linked immunosorbent assay (ELISA). Out of 124 patients with TB (66 male, age range: 10-91 years), 48 patients (38.7 %) exhibited residual cavities. Eighteen (14.5 %) patients had cavities with pleural thickening. A round-shaped mass lesion was detected in six patients (6.8 %). DME was positive in ten patients for septate fungal hyphae. A. fumigatus was grown from 14 samples. Fifty-five (44.3 %) cases were positive for serum-specific IgG against A. fumigatus. Of 124 patients with TB, 3 (2.4 %) met criteria for aspergilloma and 14 (11.3 %) for CCPA. CPA is a common clinical presentation in individuals with healed TB in Iran, as reported by previous studies from other countries.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26003310     DOI: 10.1007/s10096-015-2409-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  38 in total

1.  Clinical significance of potential pathogenic microorganisms of sputum in patients with pulmonary tuberculosis.

Authors:  M Shirai; H Hayakawa; H Uchiyama; K Chida; H Nakamura
Journal:  Respirology       Date:  2001-12       Impact factor: 6.424

2.  Multifocal pulmonary aspergillomas: case series and review.

Authors:  Matthew Pendleton; David W Denning
Journal:  Ann N Y Acad Sci       Date:  2012-12       Impact factor: 5.691

3.  Aspergillus fumigatus fungus ball in hospitalized patients with chronic pulmonary disease. Usefulness of double immunodiffusion test as a screening procedure.

Authors:  M F Ferreira-Da-Cruz; B Wanke; C Pirmez; B Galvão-Castro
Journal:  Mem Inst Oswaldo Cruz       Date:  1988 Jul-Sep       Impact factor: 2.743

4.  Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients.

Authors:  Juliette Camuset; Hilario Nunes; Marie-Christine Dombret; Anne Bergeron; Priscilla Henno; Bruno Philippe; Gaelle Dauriat; Gilles Mangiapan; Antoine Rabbat; Jacques Cadranel
Journal:  Chest       Date:  2007-03-30       Impact factor: 9.410

5.  The efficacy and tolerability of voriconazole in the treatment of chronic cavitary pulmonary aspergillosis.

Authors:  Lakshmi R Jain; David W Denning
Journal:  J Infect       Date:  2006-01-20       Impact factor: 6.072

Review 6.  The clinical spectrum of pulmonary aspergillosis.

Authors:  Chris Kosmidis; David W Denning
Journal:  Thorax       Date:  2014-10-29       Impact factor: 9.139

7.  Fatal massive hemoptysis in a patient on low-dose oral prednisone: chronic necrotizing pulmonary aspergillosis.

Authors:  Bobbak Vahid; Paul Marik
Journal:  Respir Care       Date:  2007-01       Impact factor: 2.258

8.  Mycological and serological study of pulmonary aspergillosis in central India.

Authors:  A M Kurhade; J M Deshmukh; R P Fule; C Chande; S Akulwar
Journal:  Indian J Med Microbiol       Date:  2002 Jul-Sep       Impact factor: 0.985

9.  Volume dependency for culture of fungi from respiratory secretions and increased sensitivity of Aspergillus quantitative PCR.

Authors:  Marcin G Fraczek; Marie B Kirwan; Caroline B Moore; Julie Morris; David W Denning; Malcolm D Richardson
Journal:  Mycoses       Date:  2013-06-21       Impact factor: 4.377

10.  Anergic pulmonary tuberculosis is associated with contraction of the Vd2+T cell population, apoptosis and enhanced inhibitory cytokine production.

Authors:  Liping Yan; Haiyan Cui; Heping Xiao; Qing Zhang
Journal:  PLoS One       Date:  2013-08-02       Impact factor: 3.240

View more
  15 in total

1.  Chronic pulmonary aspergillosis in patients with active pulmonary tuberculosis with persisting symptoms in Uganda.

Authors:  Martha Namusobya; Felix Bongomin; John Mukisa; William Kane Olwit; Charles Batte; Claudine Mukashyaka; Emmanuel Mande; Richard Kwizera; David W Denning; Joshua Rhein; Shailendra Prasad; Christine Sekaggya-Wiltshire
Journal:  Mycoses       Date:  2022-04-24       Impact factor: 4.931

2.  Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.

Authors:  Faezeh Mohammadi; Seyed Jamal Hashemi; Jan Zoll; Willem J G Melchers; Haleh Rafati; Parvin Dehghan; Sasan Rezaie; Ali Tolooe; Yalda Tamadon; Henrich A van der Lee; Paul E Verweij; Seyedmojtaba Seyedmousavi
Journal:  Antimicrob Agents Chemother       Date:  2015-11-02       Impact factor: 5.191

Review 3.  [Aspergillus in airway material : Ignore or treat?]

Authors:  H J F Salzer; C Lange; M Hönigl
Journal:  Internist (Berl)       Date:  2017-11       Impact factor: 0.743

Review 4.  Minimizing fungal disease deaths will allow the UNAIDS target of reducing annual AIDS deaths below 500 000 by 2020 to be realized.

Authors:  David W Denning
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-12-05       Impact factor: 6.237

Review 5.  Delivering on Antimicrobial Resistance Agenda Not Possible without Improving Fungal Diagnostic Capabilities.

Authors:  David W Denning; David S Perlin; Eavan G Muldoon; Arnaldo Lopes Colombo; Arunaloke Chakrabarti; Malcolm D Richardson; Tania C Sorrell
Journal:  Emerg Infect Dis       Date:  2017-02-15       Impact factor: 6.883

6.  The Burden of Serious Fungal Infections in Tajikistan.

Authors:  Oktam I Bobokhojaev; Ali Osmanov; Samariddin P Aliev; Asliddin S Radjabzoda; Ziyovuddin T Avgonov; Safarbek T Manonov; David W Denning
Journal:  J Fungi (Basel)       Date:  2019-07-21

Review 7.  Identification of Mycoses in Developing Countries.

Authors:  Amir Arastehfar; Brian L Wickes; Macit Ilkit; David H Pincus; Farnaz Daneshnia; Weihua Pan; Wenjie Fang; Teun Boekhout
Journal:  J Fungi (Basel)       Date:  2019-09-29

Review 8.  Chronic Pulmonary Aspergillosis-Where Are We? and Where Are We Going?

Authors:  Gemma E Hayes; Lilyann Novak-Frazer
Journal:  J Fungi (Basel)       Date:  2016-06-07

9.  Chronic pulmonary aspergillosis commonly complicates treated pulmonary tuberculosis with residual cavitation.

Authors:  Iain D Page; Rosemary Byanyima; Sharath Hosmane; Nathan Onyachi; Cyprian Opira; Malcolm Richardson; Richard Sawyer; Anna Sharman; David W Denning
Journal:  Eur Respir J       Date:  2019-03-18       Impact factor: 16.671

10.  Prevalence of invasive aspergillosis in suspected pulmonary tuberculosis at a referral tuberculosis hospital in Shandong, China.

Authors:  Jun-Li Wang; Xiao-Lin Zhou; Chao Han; Mao-Shui Wang; Hua Hu
Journal:  Epidemiol Infect       Date:  2020-11-05       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.